EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis



Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis



Molecular Immunology 48(15-16): 1958-1965



Bacillus anthracis overwhelms its victims by way of two toxins, namely edema toxin and lethal toxin. Lethal toxin is formed by the combination of protective antigen with lethal factor while edema toxin is formed by the combination of Protective Antigen with edema factor. Overlapping regions between edema factor and lethal factor have been reported in past. For the first time, this study reports characterization of a bispecific monoclonal antibody (mAb), H10, which showed high affinity interaction with both edema factor and lethal factor of B. anthracis. H10 mAb not only neutralized the adenylate cyclase activity of edema toxin but it could also neutralize the cytotoxic activity of lethal toxin. Passive immunization with this antibody gave 100% protection to mice from in vivo challenge with lethal toxin and edema toxin. The results of this study suggest future application of this bispecific monoclonal antibody as passive immunization prophylactics in cases of B. anthracis exposure and infection.

(PDF emailed within 0-6 h: $19.90)

Accession: 053865218

Download citation: RISBibTeXText

PMID: 21704379

DOI: 10.1016/j.molimm.2011.05.024



Related references

Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor. Plos One 8(5): E65855-E65855, 2014

Biochip for the Detection of Bacillus anthracis Lethal Factor and Therapeutic Agents against Anthrax Toxins. Membranes 6(3): -, 2016

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Infection and Immunity 75(11): 5425-5433, 2007

Dual effect of synthetic aminoglycosides: antibacterial activity against Bacillus anthracis and inhibition of anthrax lethal factor. Angewandte Chemie 44(3): 447-452, 2004

A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry 39(22): 6706-6713, June 6, 2000

Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor. Clinical and Vaccine Immunology 15(1): 71-75, 2007

Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics. Molecular Immunology 68(2 Pt A): 185-193, 2016

Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin. Infection and Immunity 58(6): 1606-1613, 1990

Observations on experimental anthrax: demonstration ofa specific lethal factor produced in vivo by Bacillus anthracis. Nature, Lond., 173: 869-870, 1954

An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin. Infection and Immunity 73(10): 6547-6551, 2005

Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein. Official Gazette of the United States Patent & Trademark Office Patents 121(4): 3908, Nov 24, 1998

Anthrax lethal factor: Critical virulence factor of pathogenesis of anthrax toxins. Toxin Reviews 25(1): 109-124, 2006

Monoclonal antibody against the poly-?-d-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge. Biochimica et Biophysica Acta (BBA) - General Subjects 1830(3): 2804-2812, 2013

Anthrax bacillus anthracis toxin edema factor a bacterial adenylate cyclase that increases cyclic amp concentrations in eukaryotic cells. Proceedings of the National Academy of Sciences of the United States of America 79(10): 3162-3166, 1982

Effects of Bacillus anthracis lethal and edema toxins on human macrophages. Journal of Leukocyte Biology Supplement ( ): 37, 2003